申请人:Lafanechere Laurence
公开号:US20120041017A1
公开(公告)日:2012-02-16
Pyridocarbazole-type compounds of formula (I):
are provided as a medicament, and more particularly for application in anticancer chemotherapy. Also provided is a pharmaceutical composition with the compound and methods for preventing and/or treating neurodegenerative-type pathologies, such as Alzheimer's disease and schizophrenia, parasitoses, such as malaria, or glaucomas.
提供了化学式(I)的吡啶咔唑类化合物作为药物,特别是用于抗癌化疗的应用。还提供了含有该化合物的制药组合物以及预防和/或治疗神经退行性疾病类型,如阿尔茨海默病和精神分裂症,寄生虫病,如疟疾,或青光眼的方法。